EMPREENDIMENTOS PAGUE MENOS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.51 BRL | +0.40% |
|
-4.92% | -36.62% |
| Sales 2024 * | 11.8B 2.25B | Sales 2025 * | 13.17B 2.51B | Capitalization | 1.45B 277M |
|---|---|---|---|---|---|
| Net income 2024 * | 70M 13.35M | Net income 2025 * | 153M 29.19M | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 1.24B 237M | Net Debt 2025 * | 1.1B 210M | EV / Sales 2025 * | 0.19 x |
| P/E ratio 2024 * |
32.4
x | P/E ratio 2025 * |
10.9
x | Employees | 20,099 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Empreendimentos Pague Menos S.A.
More press releases
| 1 day | +0.40% | ||
| 1 week | -4.92% | ||
| Current month | -7.38% | ||
| 1 month | -8.39% | ||
| 3 months | -27.03% | ||
| 6 months | -17.70% | ||
| Current year | -36.62% |
1 week
2.40
2.61
1 month
2.402.85
Current year
2.403.96
1 year
2.404.75
3 years
2.4013.75
5 years
2.4013.75
10 years
2.4013.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 47 | 15-12-31 | |
Gianni Dias Gill
COO | Chief Operating Officer | - | 21-06-30 |
| Chief Tech/Sci/R&D Officer | - | 01-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 11-12-31 | |
| Director/Board Member | - | 81-12-31 | |
| Director/Board Member | 52 | 97-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 2.51 | +0.40% | 729,900 |
| 24-04-17 | 2.5 | 0.00% | 776,500 |
| 24-04-16 | 2.5 | 0.00% | 1,104,900 |
| 24-04-15 | 2.5 | -3.85% | 939,400 |
| 24-04-12 | 2.6 | -1.52% | 1,035,700 |
Delayed Quote Sao Paulo, April 18, 2024 at 04:07 pm EDT
More quotes
Empreendimentos Pague Menos SA is a Brazil-based company primarily engaged in the drug retail sector. Through a drugstore chain, the Company sells medicines, perfumes, personal care and household products, cosmetics, as well as grocery goods, among others. Additionally, It offers a range of financial services, such as bill collection and credit card issuing. The Company also operates a call center that provides information related to drugs usage.
Sector
Drug Retailers
Calendar
2024-04-29
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
2.51
BRL
Average target price
3.89
BRL
Spread / Average Target
+54.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.62% | 276M | |
| -32.63% | 15.18B | |
| -41.56% | 9.47B | |
| -10.75% | 6.15B | |
| +8.02% | 6.04B | |
| -38.44% | 5.44B | |
| +2.34% | 4.86B | |
| +50.00% | 4.23B | |
| -13.27% | 3.55B | |
| -10.44% | 3.51B |
- Stock Market
- Equities
- PGMN3 Stock
